BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31010584)

  • 1. Diagnostic value of 3 T MR spectroscopy, diffusion-weighted MRI, and apparent diffusion coefficient value for distinguishing benign from malignant myometrial tumours.
    Rahimifar P; Hashemi H; Malek M; Ebrahimi S; Tabibian E; Alidoosti A; Mousavi A; Yarandi F
    Clin Radiol; 2019 Jul; 74(7):571.e9-571.e18. PubMed ID: 31010584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
    Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
    Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Namimoto T; Yamashita Y; Awai K; Nakaura T; Yanaga Y; Hirai T; Saito T; Katabuchi H
    Eur Radiol; 2009 Nov; 19(11):2756-64. PubMed ID: 19504102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative diagnosis of atypical pelvic leiomyoma and sarcoma: the potential role of diffusion-weighted imaging.
    Valdes-Devesa V; Jimenez MDM; Sanz-Rosa D; Espada Vaquero M; Alvarez Moreno E; Sainz de la Cuesta Abbad R
    J Obstet Gynaecol; 2019 Jan; 39(1):98-104. PubMed ID: 30207503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leiomyoma or sarcoma? MRI performance in the differential diagnosis of sonographically suspicious uterine masses.
    Valletta R; Corato V; Lombardo F; Avesani G; Negri G; Steinkasserer M; Tagliaferri T; Bonatti M
    Eur J Radiol; 2024 Jan; 170():111217. PubMed ID: 38042020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
    Jeon JY; Chung HW; Lee MH; Lee SH; Shin MJ
    Br J Radiol; 2016; 89(1060):20150929. PubMed ID: 26892266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic accuracy of contrast-enhanced MRI and diffusion-weighted MRI in the differentiation between uterine leiomyosarcoma / smooth muscle tumor with uncertain malignant potential and benign leiomyoma.
    Lin G; Yang LY; Huang YT; Ng KK; Ng SH; Ueng SH; Chao A; Yen TC; Chang TC; Lai CH
    J Magn Reson Imaging; 2016 Feb; 43(2):333-42. PubMed ID: 26383110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
    Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
    Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A machine learning approach for distinguishing uterine sarcoma from leiomyomas based on perfusion weighted MRI parameters.
    Malek M; Gity M; Alidoosti A; Oghabian Z; Rahimifar P; Seyed Ebrahimi SM; Tabibian E; Oghabian MA
    Eur J Radiol; 2019 Jan; 110():203-211. PubMed ID: 30599861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions.
    Davarpanah AH; Kambadakone A; Holalkere NS; Guimaraes AR; Hahn PF; Lee SI
    Abdom Radiol (NY); 2016 Dec; 41(12):2466-2475. PubMed ID: 27660280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.
    Sutter O; Soyer P; Shotar E; Dautry R; Guerrache Y; Placé V; Opréa R; Ricbourg A; Le Dref O; Boudiaf M; Sirol M; Dohan A
    Eur Radiol; 2016 Oct; 26(10):3558-70. PubMed ID: 26801165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.
    Tamai K; Koyama T; Saga T; Morisawa N; Fujimoto K; Mikami Y; Togashi K
    Eur Radiol; 2008 Apr; 18(4):723-30. PubMed ID: 17929022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperintense uterine myometrial masses on T2-weighted magnetic resonance imaging: differentiation with diffusion-weighted magnetic resonance imaging.
    Takeuchi M; Matsuzaki K; Nishitani H
    J Comput Assist Tomogr; 2009; 33(6):834-7. PubMed ID: 19940646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explorative Investigation of Whole-Lesion Histogram MRI Metrics for Differentiating Uterine Leiomyomas and Leiomyosarcomas.
    Gerges L; Popiolek D; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 May; 210(5):1172-1177. PubMed ID: 29547053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
    Rio G; Lima M; Gil R; Horta M; Cunha TM
    Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine Learning to Differentiate T2-Weighted Hyperintense Uterine Leiomyomas from Uterine Sarcomas by Utilizing Multiparametric Magnetic Resonance Quantitative Imaging Features.
    Nakagawa M; Nakaura T; Namimoto T; Iyama Y; Kidoh M; Hirata K; Nagayama Y; Yuki H; Oda S; Utsunomiya D; Yamashita Y
    Acad Radiol; 2019 Oct; 26(10):1390-1399. PubMed ID: 30661978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality fMRI with perfusion, diffusion-weighted MRI and
    Zhu L; Wang J; Shi H; Tao X
    J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T.
    Lee SY; Jee WH; Jung JY; Park MY; Kim SK; Jung CK; Chung YG
    Eur Radiol; 2016 Mar; 26(3):743-54. PubMed ID: 26080796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.